Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs12150220
rs12150220
0.010 GeneticVariation BEFREE Data showed that the NLRP1 rs12150220 missense variant (H155L) was significantly correlated with numbers of ABs in MPM patients. 29265930

2018

dbSNP: rs243865
rs243865
0.010 GeneticVariation BEFREE The <i>MMP2</i> rs243865 polymorphism may have a protective role in malignant pleural mesothelioma development. 30018519

2018

dbSNP: rs9939609
rs9939609
FTO
0.010 GeneticVariation BEFREE The present study shows for the first time that rs9939609 polymorphism in the FTO gene may be a genetic risk factor for MPM. 29260910

2018

dbSNP: rs2235503
rs2235503
0.010 GeneticVariation BEFREE We found a strong association between serum SMRP and variant alleles of rs3764247, rs3764246 (in strong linkage disequilibrium with rs2235504) and rs2235503 in non-MPM subjects. 28343162

2017

dbSNP: rs2235504
rs2235504
0.010 GeneticVariation BEFREE We found a strong association between serum SMRP and variant alleles of rs3764247, rs3764246 (in strong linkage disequilibrium with rs2235504) and rs2235503 in non-MPM subjects. 28343162

2017

dbSNP: rs3764246
rs3764246
0.010 GeneticVariation BEFREE We found a strong association between serum SMRP and variant alleles of rs3764247, rs3764246 (in strong linkage disequilibrium with rs2235504) and rs2235503 in non-MPM subjects. 28343162

2017

dbSNP: rs3764247
rs3764247
0.010 GeneticVariation BEFREE We found a strong association between serum SMRP and variant alleles of rs3764247, rs3764246 (in strong linkage disequilibrium with rs2235504) and rs2235503 in non-MPM subjects. 28343162

2017

dbSNP: rs28934574
rs28934574
0.010 GeneticVariation BEFREE We found that the MPM had R282W, a key TP53 mutation, and genome-wide allelic loss or loss of heterozygosity, a distinct genomic alteration not previously described in MPM. 26824986

2016

dbSNP: rs1508805
rs1508805
0.010 GeneticVariation BEFREE GMDR analysis showed a strong MPM risk due to asbestos exposure and suggested a possible synergistic effect between asbestos exposure and rs1508805, rs2501618 and rs5756444. 26139392

2015

dbSNP: rs2501618
rs2501618
0.010 GeneticVariation BEFREE GMDR analysis showed a strong MPM risk due to asbestos exposure and suggested a possible synergistic effect between asbestos exposure and rs1508805, rs2501618 and rs5756444. 26139392

2015

dbSNP: rs5756444
rs5756444
0.010 GeneticVariation BEFREE GMDR analysis showed a strong MPM risk due to asbestos exposure and suggested a possible synergistic effect between asbestos exposure and rs1508805, rs2501618 and rs5756444. 26139392

2015

dbSNP: rs12947788
rs12947788
0.010 GeneticVariation BEFREE Interestingly, TP53 polymorphisms in intron 7 (rs12947788 and rs12951053) were more frequently identified in asbestos-exposed NSCLC (P = 0.046) and MPM patients than in unexposed patients (P < 0.001 and P = 0.012, respectively). 23435014

2013

dbSNP: rs12951053
rs12951053
0.010 GeneticVariation BEFREE Interestingly, TP53 polymorphisms in intron 7 (rs12947788 and rs12951053) were more frequently identified in asbestos-exposed NSCLC (P = 0.046) and MPM patients than in unexposed patients (P < 0.001 and P = 0.012, respectively). 23435014

2013

dbSNP: rs16906252
rs16906252
0.010 GeneticVariation BEFREE Thirteen of the 95 MPM samples (13.7%) were methylation positive and a strong association with the T allele of the rs16906252 SNP (P<0.001) was observed. 20627446

2011

dbSNP: rs1041983
rs1041983
0.010 GeneticVariation BEFREE On the other hand, the nucleotidic change 282C>T within NAT2 held the statistical significance (OR=3.54; 95% CI 1.75-7.16; p=0.0002), reinforcing existing evidences that describe genetic polymorphisms of NAT2 possibly involved in the etiology of the MPM. 19751749

2009